These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12766251)

  • 1. A small molecule alpha4beta1/alpha4beta7 antagonist differentiates between the low-affinity states of alpha4beta1 and alpha4beta7: characterization of divalent cation dependence.
    Egger LA; Cao J; McCallum C; Kidambi U; Van Riper G; McCauley E; Mumford RA; Lanza TJ; Lin LS; de Laszlo SE; Young DN; Yang G; Dean DC; Raab CE; Wallace MA; Jones AN; Hagmann WK; Schmidt JA; Pepinsky RB; Scott DM; Lee WC; Cornebise MA; Detmers PA
    J Pharmacol Exp Ther; 2003 Sep; 306(3):903-13. PubMed ID: 12766251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of divalent cations on the affinity and selectivity of alpha4 integrins towards the integrin ligands vascular cell adhesion molecule-1 and mucosal addressin cell adhesion molecule-1: Ca2+ activation of integrin alpha4beta1 confers a distinct ligand specificity.
    Day ES; Osborn L; Whitty A
    Cell Commun Adhes; 2002; 9(4):205-19. PubMed ID: 12699089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that ligand and metal ion binding to integrin alpha 4beta 1 are regulated through a coupled equilibrium.
    Chen LL; Whitty A; Scott D; Lee WC; Cornebise M; Adams SP; Petter RC; Lobb RR; Pepinsky RB
    J Biol Chem; 2001 Sep; 276(39):36520-9. PubMed ID: 11473127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and analysis of a polyethelene glycol-modified (PEGylated) small molecule inhibitor of integrin {alpha}4{beta}1 with improved pharmaceutical properties.
    Pepinsky RB; Lee WC; Cornebise M; Gill A; Wortham K; Chen LL; Leone DR; Giza K; Dolinski BM; Perper S; Nickerson-Nutter C; Lepage D; Chakraborty A; Whalley ET; Petter RC; Adams SP; Lobb RR; Scott DM
    J Pharmacol Exp Ther; 2005 Feb; 312(2):742-50. PubMed ID: 15485895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists.
    Gong Y; Barbay JK; Dyatkin AB; Miskowski TA; Kimball ES; Prouty SM; Fisher MC; Santulli RJ; Schneider CR; Wallace NH; Ballentine SA; Hageman WE; Masucci JA; Maryanoff BE; Damiano BP; Andrade-Gordon P; Hlasta DJ; Hornby PJ; He W
    J Med Chem; 2006 Jun; 49(11):3402-11. PubMed ID: 16722660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD14 is a ligand for the integrin alpha4beta1.
    Humphries JD; Humphries MJ
    FEBS Lett; 2007 Feb; 581(4):757-63. PubMed ID: 17274987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses.
    Lin Kc; Ateeq HS; Hsiung SH; Chong LT; Zimmerman CN; Castro A; Lee WC; Hammond CE; Kalkunte S; Chen LL; Pepinsky RB; Leone DR; Sprague AG; Abraham WM; Gill A; Lobb RR; Adams SP
    J Med Chem; 1999 Mar; 42(5):920-34. PubMed ID: 10072689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ligand binding sites on integrin alpha4beta1 through chemical cross-linking.
    Chen LL; Lobb RR; Cuervo JH; Lin Kc; Adams SP; Pepinsky RB
    Biochemistry; 1998 Jun; 37(24):8743-53. PubMed ID: 9628736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of the ligand and metal ion binding properties of integrins alpha9beta1 and alpha4beta1.
    Pepinsky RB; Mumford RA; Chen LL; Leone D; Amo SE; Riper GV; Whitty A; Dolinski B; Lobb RR; Dean DC; Chang LL; Raab CE; Si Q; Hagmann WK; Lingham RB
    Biochemistry; 2002 Jun; 41(22):7125-41. PubMed ID: 12033947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent in vivo suppression of inflammation by selectively targeting the high affinity conformation of integrin α4β1.
    Vanderslice P; Woodside DG; Caivano AR; Decker ER; Munsch CL; Sherwood SJ; Lejeune WS; Miyamoto YJ; McIntyre BW; Tilton RG; Dixon RA
    Biochem Biophys Res Commun; 2010 Oct; 400(4):619-24. PubMed ID: 20807504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4.
    Okigami H; Takeshita K; Tajimi M; Komura H; Albers M; Lehmann TE; Rölle T; Bacon KB
    Eur J Pharmacol; 2007 Mar; 559(2-3):202-9. PubMed ID: 17234179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple activation states of integrin alpha4beta1 detected through their different affinities for a small molecule ligand.
    Chen LL; Whitty A; Lobb RR; Adams SP; Pepinsky RB
    J Biol Chem; 1999 May; 274(19):13167-75. PubMed ID: 10224072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion of multiple myeloma peripheral blood B cells to bone marrow fibroblasts: a requirement for CD44 and alpha4beta7.
    Masellis-Smith A; Belch AR; Mant MJ; Pilarski LM
    Cancer Res; 1997 Mar; 57(5):930-6. PubMed ID: 9041197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A label-free approach to identify inhibitors of alpha4beta7-mediated cell adhesion to MadCAM.
    Bova MP; Nguyen L; Wallace W; Garrido C; Xu YZ; Semko C; Cockcroft K; Sandberg E; Bard F
    J Biomol Screen; 2011 Jun; 16(5):536-44. PubMed ID: 21406619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective cell adhesion inhibitors: Barbituric acid based alpha4beta7--MAdCAM inhibitors.
    Harriman GC; Brewer M; Bennett R; Kuhn C; Bazin M; Larosa G; Skerker P; Cochran N; Gallant D; Baxter D; Picarella D; Jaffee B; Luly JR; Briskin MJ
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2509-12. PubMed ID: 18331794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aza-bicyclic amino acid carboxamides as alpha4beta1/alpha4beta7 integrin receptor antagonists.
    Dyatkin AB; Gong Y; Miskowski TA; Kimball ES; Prouty SM; Fisher MC; Santulli RJ; Schneider CR; Wallace NH; Hornby PJ; Diamond C; Kinney WA; Maryanoff BE; Damiano BP; He W
    Bioorg Med Chem; 2005 Dec; 13(24):6693-702. PubMed ID: 16112583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of the mechanistic differences between two integrin alpha 4 beta 1 inhibitors, the monoclonal antibody TA-2 and the small molecule BIO5192, in rat experimental autoimmune encephalomyelitis.
    Leone DR; Giza K; Gill A; Dolinski BM; Yang W; Perper S; Scott DM; Lee WC; Cornebise M; Wortham K; Nickerson-Nutter C; Chen LL; LePage D; Spell JC; Whalley ET; Petter RC; Adams SP; Lobb RR; Pepinsky RB
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1150-62. PubMed ID: 12626659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation pathways of alpha4beta1 integrin leading to distinct T-cell cytoskeleton reorganization, Rac1 regulation and Pyk2 phosphorylation.
    Maqueda A; Moyano JV; Gutiérrez-López MD; Ovalle S; Rodríguez-Frade JM; Cabañas C; Garcia-Pardo A
    J Cell Physiol; 2006 Jun; 207(3):746-56. PubMed ID: 16514607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotaviruses interact with alpha4beta7 and alpha4beta1 integrins by binding the same integrin domains as natural ligands.
    Graham KL; Fleming FE; Halasz P; Hewish MJ; Nagesha HS; Holmes IH; Takada Y; Coulson BS
    J Gen Virol; 2005 Dec; 86(Pt 12):3397-3408. PubMed ID: 16298987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small molecule, orally active, alpha4beta1/alpha4beta7 dual antagonist reduces leukocyte infiltration and airway hyper-responsiveness in an experimental model of allergic asthma in Brown Norway rats.
    Cortijo J; Sanz MJ; Iranzo A; Montesinos JL; Nabah YN; Alfón J; Gómez LA; Merlos M; Morcillo EJ
    Br J Pharmacol; 2006 Mar; 147(6):661-70. PubMed ID: 16432509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.